19 September 2019

Prestigious International Award to Diabetes Researcher

Prize

Professor, Chief Physician and Head of Research Filip Krag Knop is being honoured with this year’s ‘Minkowski Prize’ at the congress of the European Association for the Study of Diabetes – EASD – in Barcelona. The award is given in recognition of excellent contributions to the advancement of knowledge concerning diabetes.

Filip Krag Knop

- The Minkowski Prize is one of the major international diabetes awards – so it is a huge honour to receive it, says Filip Krag Knop, who will accept the award on 19 September in Barcelona.

Filip Krag Knop is a professor at the Department of Clinical Medicine and affiliated with the Novo Nordisk Foundation Center for Basic and Metabolic Research at SUND. Also, he is the head of the Center for Clinical Metabolic Research at Herlev-Gentofte Hospital – where he is also a chief physician – and employed at the Steno Diabetes Center Copenhagen, where he treats patients.

It has been 14 years since a Dane was last honoured with this award which has been handed out since 1966. And it is with a certain awe that Filip Krag Knop now joins the ranks of recipients of the award which is given in recognition of excellent advancement of knowledge concerning diabetes.

‘When I see the list of past recipients, I don’t think that I have ever found myself in a better company. It is a great recognition of me and my research team and a reminder that the projects we are working on – mainly based on our curiosity – are also being noticed by others. Naturally, you feel honoured and delighted. You also get motivated to continue’, he says.

Research of the Highest Quality
The President of the European Association for the Study of Diabetes, EASD, Professor David R. Matthews, has the following comment to the selection of Filip Krag Knop:

- This is a scientist who performs diabetes research of the highest possible quality. His research has contributed significantly to our understanding of the hormone glucagon and its importance for diabetic pathophysiology, i.e. the disease progression in diabetes, and may set new goals for the future treatment of diabetes. I would like to congratulate Filip Krag Knop on his excellent research results; he is obviously a worthy recipient of the award.

Patient-Specific Research
Filip Krag Knop's research is particularly focused on the mechanisms behind the development of severe obesity and the complications of severe obesity, such as non-alcoholic fatty liver disease and type 2 diabetes, which are some of the most common diseases in the Western world. At the same time, it is very important to him that his research cuts across medical specialties and that it will benefit the patients as quickly as possible.

- It is my hope to develop the Center for Clinical Metabolic Research at Herlev-Gentofte Hospital in such a way that doctors and researchers from various specialties and fields have access to state-of-the-art clinical metabolism research. Many medical specialties without any tradition of clinical metabolism research have already begun to realise the important discoveries that lie ahead and the benefits that new knowledge within the field may have for their patients, says Filip Krag Knop.